Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease

J. Y. Chen, Y. Stern, M. Sano and R. Mayeux
Department of Neurology, Columbia University, College of Physicians and Surgeons, New York, NY.

Cumulative risks of developing extrapyramidal signs, psychosis, and myoclonus in the course of Alzheimer's disease (AD) were estimated in 72 patients with probable AD by the Kaplan-Meier survival method. The cumulative risk functions were found to increase at different rates for different signs as AD progressed. Comparisons of the cumulative risk functions revealed that in the early stages of AD, extrapyramidal signs and psychosis were more likely to develop than myoclonus. As AD progressed, the risk of developing myoclonus became as great as that of developing the other two signs. This study suggests that extrapyramidal signs, psychosis, and myoclonus represent developmental features that mark the progression of AD, rather than indicators of disease subtypes. The estimated cumulative risk functions set a reasonable expectation for the timing and likelihood of the emergence of the clinical signs. This, in turn, might aid in disease prognosis because the biological bases of these signs have been established and they have been shown to be predictive of other markers of disease course.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epidemiology of and Risk Factors for Psychosis of Alzheimer's Disease: A Review of 55 Studies Published From 1990 to 2003
Ropacki and Jeste
Am. J. Psychiatry 2005;162:2022-2030.
ABSTRACT | FULL TEXT  

Motor signs during the course of Alzheimer disease
Scarmeas et al.
Neurology 2004;63:975-982.
ABSTRACT | FULL TEXT  

Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease
Levy et al.
Arch Neurol 2004;61:1033-1039.
ABSTRACT | FULL TEXT  

Review of delusions in dementia
Fischer et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2004;19:19-23.
ABSTRACT  

Neuromotor abnormalities and risk for psychosis in Alzheimer's disease
Caligiuri et al.
Neurology 2003;61:954-958.
ABSTRACT | FULL TEXT  

Delusions and Hallucinations in Alzheimer's Disease: Review of the Brain Decade
Bassiony and Lyketsos
Psychosomatics 2003;44:388-401.
ABSTRACT | FULL TEXT  

Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease
Scarmeas et al.
Neurology 2002;58:1182-1188.
ABSTRACT | FULL TEXT  

Extrapyramidal symptoms and signs in Alzheimer's disease: Pravalence and correlation with the first symptom
Tsolaki et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2001;16:268-278.
ABSTRACT  

Hallucinations, delusions, and cognitive decline in Alzheimer's disease
Wilson et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:172-177.
ABSTRACT | FULL TEXT  

Progression of Parkinsonism and Loss of Cognitive Function in Alzheimer Disease
Wilson et al.
Arch Neurol 2000;57:855-860.
ABSTRACT | FULL TEXT  

Predictors of progression in patients with AD and Lewy bodies
Lopez et al.
Neurology 2000;54:1774-1779.
ABSTRACT | FULL TEXT  

Progression of parkinsonian signs in Alzheimer's disease
Wilson et al.
Neurology 2000;54:1284-1289.
ABSTRACT | FULL TEXT